The Effect of Supplementation with a Cysteine Donor on Muscular Performance
Human study of a whey-based cysteine donor and muscular performance.
Open in PubMed →A tool to separate what has been studied in people from animal or laboratory work and from reviews. Every record in the verified core links directly to PubMed.
This resource combines two layers: the historical 92-publication collection already organized by Mas Glutation and a manually verified PubMed core. A literal PubMed search for “Immunocal” can include unrelated products sharing the same name, so the raw result count is not used as the number of nutritional-product studies.
Methods review: 18 August 2026.
Records checked individually and classified by design. Original titles are preserved for traceability.
Human study of a whey-based cysteine donor and muscular performance.
Open in PubMed →Human study of undenatured whey supplementation and exercise-induced bronchoconstriction.
Open in PubMed →Randomized double-blind study in non-frail older adults combined with resistance training.
Open in PubMed →Study in young adults with cystic fibrosis evaluating whey protein and glutathione status.
Open in PubMed →Double-blind study in advanced HIV infection focused on plasma glutathione and tolerability.
Open in PubMed →Clinical study of oral whey-protein supplementation in HIV infection and plasma glutathione.
Open in PubMed →Open study in chronic hepatitis B or C using non-heated whey protein; findings differed between groups.
Open in PubMed →Very small phase I-II clinical study in metastatic carcinoma; it should be read as exploratory evidence.
Open in PubMed →Pilot study in Parkinson’s disease examining whey-protein supplementation and biochemical/clinical variables.
Open in PubMed →Open-label study in patients with pressure ulcers; a clinical signal, not blinded evidence.
Open in PubMed →Randomized double-blind controlled study of cysteine-rich whey protein in children with ASD; the authors call for confirmation.
Open in PubMed →Review of Immunocal, glutathione synthesis and proposed neuroprotective mechanisms; not a clinical trial.
Open in PubMed →Preclinical research in a mouse model of ALS; it does not establish clinical efficacy in people.
Open in PubMed →Preclinical study in GFAP.HMOX1 transgenic mice; it should be read as mechanistic research.
Open in PubMed →In-vitro work on oxidative stress and cellular glutathione; it is not clinical outcome evidence.
Open in PubMed →Preclinical controlled-cortical-impact mouse model of traumatic brain injury.
Open in PubMed →Preclinical mouse models of repetitive mild traumatic brain injury focused on gliosis/neuroinflammation.
Open in PubMed →Preclinical transgenic mouse model of Alzheimer’s disease; this is not human clinical evidence.
Open in PubMed →In-vitro cancer-cell/drug study; it cannot establish a therapeutic effect in patients.
Open in PubMed →No matching records.
It can help identify study design, population/model and the original source.
It cannot turn preclinical results, pilot signals or reviews into therapeutic promises for an individual.
Mas Glutation (2026). Glutathione and Immunocal scientific evidence map. Review 2026-08-18.
Do not turn research into endless waiting. Choose a formula, review its page and check the official-store price.